Matches in Nanopublications for { ?s ?p "[Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1211287.RASyfs6_1NBQE60wCWdmAVJPhK5Ui8rwdiVMzlhqf3Yfo130_assertion description "[Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211287.RASyfs6_1NBQE60wCWdmAVJPhK5Ui8rwdiVMzlhqf3Yfo130_provenance.
- NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_assertion description "[Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211288.RA0QnFtjLfSFFouB55FeiCo-0EYOyIgSGiZqoOp16uBXw130_provenance.